Minnesota state-covered entities generated at least $1.34 billion in net 340B revenue in calendar year 2024 — more than double the $630 million reported in 2023.
A Feb. 27 report to the Legislature from the Minnesota Department of Health said covered entities reported $3.04 billion in reimbursements against $1.53 billion in acquisition costs and $165 million in operational expenses.
The department said 2024’s $1.34 billion total likely understates actual revenue due to challenges capturing office-administered drugs. The figure also includes $64 million in estimated missing reimbursements.
Of 204 covered entities required to report in 2025, 198 submitted data, reflecting a 97% response rate. The analysis ultimately included 181 entities.
The state’s 23 general acute care hospitals generated $1,082,379,896 in net 340B revenue, accounting for more than 80% of the statewide total.
Operational expenses included $120 million in contract pharmacy payments and $17 million in other external costs. The report also cited approximately 1,172 child sites and 2,472 contractual agreements with outpatient pharmacies tied to Minnesota parent covered entities.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
